Tinglykke Byg ApS: Financial statements 2019
CVR: 37449490
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Tinglykke Byg ApS (CVR 37449490) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,141 and a net result of DKK 221 compared with DKK 4,101 the year before. Equity in the 2019 report amounted to DKK 125,577. The solvency ratio was 94.7%.
- Gross Profit
- DKK -1,141
- Profit/Loss
- DKK 221
- Equity
- DKK 125,577
- Total Assets
- DKK 132,623
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1K | 221 | 126K | - |
| 2018 | - | 4K | 4K | 125K | - |
| 2017 | - | -8K | -9K | 121K | - |
| 2016 | - | -3K | 5K | 130K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Tinglykke Byg ApS has published its annual report for 2018. Gross profit came to DKK 4,369, and the net result was DKK 4,101.
About Tinglykke Byg ApS
Tinglykke Byg ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2016. The company is registered under the industry Tømrer- og bygningssnedkeraktiviteter. The company was previously named Labcon Engineering ApS. The management consists of Michael Maul Svarrer. The company is owned by PHARMA NORD ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,117,435 and a net result of DKK 38,323 compared with DKK 51,516 the year before. Equity in the 2025 report amounted to DKK 215,155.